Oxychlorosene 4 MG/ML Topical Solution [Clorpactin WCS-90] — RxCUI 672965
RxNorm drug concept · Semantic branded drug
RxCUI 672965
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI672965
Official nameOxychlorosene 4 MG/ML Topical Solution [Clorpactin WCS-90]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asClorpactin WCS-90 4 MG/ML Topical Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Oxychlorosene 4 MG/ML Topical Solution [Clorpact... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Oxychlorosene 4 MG/ML Topical Solution [Clorpactin WCS-90]
RxCUI 672965 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Oxychlorosene
32680IN
-
Oxychlorosene
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Clorpactin WCS-90
92187BN
-
Clorpactin WCS-90
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Oxychlorosene Topical Solution
374487SCDF -
Oxychlorosene Topical Product
1160158SCDG -
Oxychlorosene Topical Solution [Clorpactin WCS-90]
365512SBDF -
Clorpactin WCS-90 Topical Product
1173697SBDG -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Oxychlorosene Topical Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Oxychlorosene 4 MG/ML Topical Solution
672963SCD -
Oxychlorosene 4 MG/ML
672962SCDC -
Oxychlorosene 4 MG/ML [Clorpactin WCS-90]
672964SBDC
-
Oxychlorosene 4 MG/ML Topical Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Oxychlorosene 4 MG/ML Topical Solution
SCD · 672963 -
Oxychlorosene 4 MG/ML
SCDC · 672962 -
Oxychlorosene Topical Solution
SCDF · 374487 -
Oxychlorosene Topical Product
SCDG · 1160158
Brand-Name Concepts
-
Oxychlorosene 4 MG/ML [Clorpactin WCS-90]
SBDC · 672964 -
Oxychlorosene Topical Solution [Clorpactin WCS-90]
SBDF · 365512 -
Clorpactin WCS-90 Topical Product
SBDG · 1173697 -
Clorpactin WCS-90
BN · 92187
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 672965 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00327-0001-10 | 5 VIAL in 1 BOX (0327-0001-10) / 2 g in 1 VIAL | Clorpactin WCS-90 | United-Guardian, Inc. | 1955-01-01 |
Observed labelers:
United-Guardian, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.